Turn Therapeutics Inc. (TTRX) Current Reports & Earnings Releases
Upcoming
- 2026-11-12 Earnings Release Estimated
| Filed | Form | Items | Filing |
|---|---|---|---|
| 2026-08-18 | 8-K | Unregistered Sales | SEC |
| 2026-08-17 | 8-K | Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2026-08-12 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2026-07-28 | 8-K | Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2026-07-07 | 8-K | Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2026-06-03 | 8-K | Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2026-06-01 | 8-K | Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2026-05-27 | 8-K | Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2026-05-19 | 8-K | Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2026-05-18 | 8-K | Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2026-05-11 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2026-03-31 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2026-03-24 | 8-K | Material Agreement, Direct Financial Obligation, Unregistered Sales, Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2026-02-17 | 8-K | Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2026-02-09 | 8-K | Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2026-01-12 | 8-K | Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2026-01-07 | 8-K | Officer / Director Changes, Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2025-11-13 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2025-11-12 | 8-K | Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2025-11-04 | 8-K | Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2025-10-30 | 8-K | Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2025-10-28 | 8-K | Material Agreement, Financial Statements & Exhibits | SEC |
| 2025-10-22 | 8-K | Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2025-10-02 | 8-K | Material Agreement, Item 3.03, Officer / Director Changes, Charter Amendments, Financial Statements & Exhibits | SEC |
Sourced from SEC EDGAR 8-K/6-K filings. 8-K is the current-report form for US domestic issuers (Item 2.02 = earnings release); 6-K is the equivalent for foreign private issuers, including ADRs. Originals live on sec.gov.